| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/29/2015 | US20150031627 Therapeutically active compounds and their methods of use |
| 01/29/2015 | US20150031626 Adam22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease |
| 01/29/2015 | US20150031625 Targeted vectors for cancer immunotherapy |
| 01/29/2015 | US20150031623 Thrombopoietin receptor ligands for neuroprotection |
| 01/29/2015 | US20150031617 Use of thymosin alpha for treatment of purulent rhinosinusitis |
| 01/29/2015 | US20150031616 Use of relaxin to treat placental syndromes |
| 01/29/2015 | US20150031615 Growth Hormone Releasing Peptides |
| 01/29/2015 | US20150031614 Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor |
| 01/29/2015 | US20150031613 Methods and compositions comprising desmopressin in combination wtih a beta-3-adrenergic receptor agonist |
| 01/29/2015 | US20150031610 Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins |
| 01/29/2015 | US20150031609 Methods and compositions for delivering peptides |
| 01/29/2015 | US20150031608 Lipid construct for delivery of insulin to a mammal |
| 01/29/2015 | US20150031606 Compositions comprising a delivery agent and preparation thereof |
| 01/29/2015 | US20150031605 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| 01/29/2015 | US20150031604 Cyclic polypeptides for the treatment of heart failure |
| 01/29/2015 | US20150031603 Macrocyclic compounds for suppressing replication of hepatitis c virus |
| 01/29/2015 | US20150031601 Antimicrobial Peptide Variants and Polynucleotides Encoding Same |
| 01/29/2015 | US20150031599 Hemoglobin compositions |
| 01/29/2015 | US20150031544 Dry glassy composition comprising a bioactive material |
| 01/29/2015 | US20150031543 Compositions for aerosolization of highly conductive solutions |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030700 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs |
| 01/29/2015 | US20150030699 Anti-tumor adjuvant therapy |
| 01/29/2015 | US20150030697 Treatments for gastrointestinal disorders |
| 01/29/2015 | US20150030688 Honey and growth factor eluting scaffold for wound healing and tissue engineering |
| 01/29/2015 | US20150030686 Self-assembled toroidal-spiral particles and manufacture and uses thereof |
| 01/29/2015 | US20150030679 Stable, durable granules with active agents |
| 01/29/2015 | US20150030678 Methods and Compositions for Treating Wounds and Reducing the Risk of Incisional Hernias |
| 01/29/2015 | US20150030642 Polymer micro-needle array chip, preparation process and use thereof |
| 01/29/2015 | US20150030641 Glucose-responsive microgels for closed loop insulin delivery |
| 01/29/2015 | US20150030633 Application of mrna for use as a therapeutic against tumour diseases |
| 01/29/2015 | US20150030620 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 01/29/2015 | US20150030617 Low density lipoprotein - related protein 6 (lrp6) - half life extender constructs |
| 01/29/2015 | US20150030604 Method of blocking vascular leakage using an anti-ang2 antibody |
| 01/29/2015 | US20150030603 Anti-ang2 antibody |
| 01/29/2015 | US20150030594 Bioconjugates of synthetic apelin polypeptides |
| 01/29/2015 | US20150030593 Compositions of penetration-enhanced targeting proteins and methods of use |
| 01/29/2015 | US20150030584 Transport protein which is used to introduce chemical compounds into nerve cells |
| 01/29/2015 | US20150030583 Methods of Treating Serosal Cancer |
| 01/29/2015 | US20150030582 Lysosomal Storage Disease Enzyme |
| 01/29/2015 | US20150030580 Pegylated fibrinogen precursor molecule |
| 01/29/2015 | US20150030576 Methods and compositions for targeting agents into and across the blood-brain barrier |
| 01/29/2015 | US20150030575 Orally administered plastid expressed cholera toxin b subunit-exendin 4 as treatment for type 2 diabetes |
| 01/29/2015 | US20150030574 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof |
| 01/29/2015 | US20150030568 Use of Stem Cells to Generate Inner Ear Cells |
| 01/29/2015 | US20150030564 Inhibitory agent for body cavity fluid accumulation |
| 01/29/2015 | US20150030562 Methods of treating or preventing viral diseases by blocking interleukin-21 |
| 01/29/2015 | US20150030561 Use of CXCR4 Antagonists |
| 01/29/2015 | US20150030533 Compositions and methods for the detection diagnosis and therapy of hematological malignancies |
| 01/29/2015 | DE102013012432A1 Immuntherapie von Prostatakrebs Immunotherapy of Prostate Cancer |
| 01/29/2015 | CA2857872A1 Composition for polyunsaturated fatty acids encapsulation and process of preparation |
| 01/28/2015 | EP2829609A1 Human CTLA-4 antibodies and their uses |
| 01/28/2015 | EP2829549A2 Hybrid and tandem expression of neisserial derived proteins |
| 01/28/2015 | EP2829285A1 Recombinant lentiviral vector formulation |
| 01/28/2015 | EP2829280A1 Treating dyspnea associated with acute heart failure with H2 relaxin |
| 01/28/2015 | EP2829279A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/28/2015 | EP2829278A1 Serum for the treatment of diseases |
| 01/28/2015 | EP2828285A1 Hb-egf inhibitor derived from the r domain of diphtheria toxin for the treatment of diseases associated with the activation of the hb-egf/egfr pathway |
| 01/28/2015 | EP2828281A1 Peptides for management of lactation |
| 01/28/2015 | EP2828280A1 Plif multimeric peptides and uses thereof |
| 01/28/2015 | EP2827907A1 Short antimicrobial lipopeptides |
| 01/28/2015 | EP2827896A1 Stable peptide mimetics of the hiv-1 gp41 pre-hairpin intermediate |
| 01/28/2015 | EP2827890A1 Immunomodulatory agent and uses therefor |
| 01/28/2015 | EP2827888A1 Lactoferrin for preventing or treating diarrhea |
| 01/28/2015 | EP2827887A1 Method of enhancing efficacy of blood transfusions |
| 01/28/2015 | EP2827886A1 Devices and methods for preventing platelet activation |
| 01/28/2015 | EP2827885A1 Compositions of glp-1 peptides and preparation thereof |
| 01/28/2015 | EP2827884A1 Silk reservoirs for drug delivery |
| 01/28/2015 | EP2827883A1 Tfpi inhibitors and methods of use |
| 01/28/2015 | EP2827882A1 Systems, compositions, and methods for transplantation |
| 01/28/2015 | EP2827878A1 Medicament for the treatment of acute myeloid leukemia (aml) |
| 01/28/2015 | EP2827845A1 Compositions comprising a delivery agent and preparation thereof |
| 01/28/2015 | EP2827841A1 Compositions and uses of antimicrobial materials with tissue-compatible properties |
| 01/28/2015 | EP2827840A1 Cyclosporin a-based aqueous ophthalmic solution |
| 01/28/2015 | CN1890262B 抗凝血酶Ⅲ组合物的制造方法 The method of producing the composition of antithrombin Ⅲ |
| 01/28/2015 | CN104321337A 肽及其用途 Peptides and their use |
| 01/28/2015 | CN104321336A 管理哺乳的肽 Lactation management peptide |
| 01/28/2015 | CN104321078A 抗原和抗原组合 Antigens and antigen combinations |
| 01/28/2015 | CN104321076A 抗凝血酶在治疗子痫前期中的应用 Antithrombin in the treatment of pre-eclampsia |
| 01/28/2015 | CN104321075A 乳铁蛋白补充和腹泻 Lactoferrin supplements and diarrhea |
| 01/28/2015 | CN104321074A 生长抑素类似物与11β-羟化酶抑制剂的组合 Somatostatin analogues in combination with 11β- hydroxylase inhibitors |
| 01/28/2015 | CN104321073A 包含骨桥蛋白及含钙和/或锶粒子的纳米粒子聚集体 Containing osteopontin and calcium and / or strontium nanoparticles particle aggregates |
| 01/28/2015 | CN104321072A 神经调节蛋白在治疗外周神经损伤中的应用 Neuregulin used in the treatment of peripheral nerve injury |
| 01/28/2015 | CN104321071A Nmda受体调节剂及其用途 Nmda receptor modulators and their use |
| 01/28/2015 | CN104321070A Alk1拮抗剂及其在治疗肾细胞癌中的用途 Alk1 antagonists and their use in the treatment of renal cell carcinoma |
| 01/28/2015 | CN104321069A 编码视杆细胞来源的视锥细胞活力因子的载体 Encoding rod cells derived cone viability factor vectors |
| 01/28/2015 | CN104321052A 在大肠中特异性崩解的胶囊 Specifically in the large intestine disintegrating capsules |
| 01/28/2015 | CN104313095A 一种活性肽组合物、其制备方法和包含其的胶囊 An active peptide composition, its preparation and its capsule comprising |
| 01/28/2015 | CN104313041A 重组细菌肌醇六磷酸酶及其用途 Recombinant bacterial phytase and its use |
| 01/28/2015 | CN104312995A 高甘露糖蛋白质和产生高甘露糖蛋白质的方法 High mannose protein and method for producing a high mannose protein |
| 01/28/2015 | CN104312994A 调节性t细胞的亚磷蛋白及其应用 Regulatory protein and phosphorous application t cells |
| 01/28/2015 | CN104311696A 一种低聚海藻酸钠制备在药品保健品及食盐制品中的应用 Preparation of an oligomeric alginate applications in the pharmaceutical and health care products in the salt |
| 01/28/2015 | CN104311672A 一种具有肿瘤细胞靶向性的抑制剂多肽 An inhibitor of tumor cell targeting polypeptide having |
| 01/28/2015 | CN104311671A 猫长效融合干扰素及其制备方法与应用 Interferon and its preparation method and application integration Long cat |
| 01/28/2015 | CN104311670A 针对IL-17和TNFα的融合多肽及其应用 For IL-17 and TNFα fusion polypeptides and their application |
| 01/28/2015 | CN104311658A 新的受体核酸及多肽 The new receptor nucleic acids and peptides |
| 01/28/2015 | CN104311657A 双酰化glp-1衍生物 Bis acylated glp-1 derivative |
| 01/28/2015 | CN104311656A cFGF-21蛋白及其在治疗类风湿关节炎中的应用 cFGF-21 protein and its application in the treatment of rheumatoid arthritis |
| 01/28/2015 | CN104311645A 具有抑菌活性的螺旋藻多肽p1及其应用 Spirulina has antibacterial activity of peptides p1 and its application |
| 01/28/2015 | CN104311644A 多肽、提高多肽稳定性的方法、药物组合物以及多肽在制备药物中的用途 Polypeptide, a method to improve the stability of the polypeptide, and polypeptide pharmaceutical compositions in the manufacture of a medicament |